Outcomes of patients treated with renal replacement therapy after cardiac surgery
Outcome of Patients Treated With Renal Replacement Therapy
Nanjing Medical University · NCT04405830
This study looks at how well kidney treatment helps critically ill patients who have heart surgery and develop kidney problems during their hospital stay.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Nanjing Medical University (other) |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT04405830 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the outcomes of critically ill patients who undergo renal replacement therapy (RRT) following cardiac surgery. It aims to evaluate both short-term and long-term effects of RRT on patients who experience acute kidney injury (AKI) during their hospital stay. The study will include patients over 18 years of age who are admitted to intensive care units and receiving RRT for renal support. By analyzing these outcomes, the study seeks to provide insights into the effectiveness of RRT in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are critically ill patients over 18 years old who are undergoing cardiovascular surgery and require renal replacement therapy.
Not a fit: Patients under 18 years of age or those who refuse consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of RRT outcomes, potentially leading to better management strategies for patients with AKI after cardiac surgery.
How similar studies have performed: Other studies have explored outcomes of renal replacement therapy in similar contexts, suggesting that this approach has been previously tested with varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Critically ill patients undergoing cardiovascular surgery admitted to intensive care units. * Patients receiving RRT for renal support * Patients over 18 years of age Exclusion Criteria: * Patients \<18 years * Refusal of consent
Where this trial is running
Nanjing, Jiangsu
- The first affiliated hospital of nanjing medical university — Nanjing, Jiangsu, China (RECRUITING)
Study contacts
- Study coordinator: Hong Liu, MD
- Email: DR.HONGLIU@FOXMAIL.COM
- Phone: 18801281613
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Kidney Injury, Cardiac Surgery